Market Overview:
The global premium intraocular lens market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The increasing prevalence of eye disorders, rising geriatric population, and technological advancements are some of the major factors driving the growth of this market. By type, the multifocal IOLs segment is expected to account for the largest share in terms of revenue in 2018, followed by accommodating IOLs and extended depth-of-focus (EDOF) IOLs segments. By application, hospitals and clinics segment is expected to account for the largest share in terms of revenue in 2018, followed by ambulatory surgery centers (ASC) segment. Geographically, North America is estimated to hold the largest share in terms of revenue in 2018; however Asia Pacific is projected to grow at a highest CAGR during the forecast period from 2018 to 2030 owing to increasing awareness about ophthalmic diseases and growing healthcare expenditure across emerging countries such as China and India.
Product Definition:
A Premium Intraocular Lens (IOL) is a lens that is implanted in the eye during cataract surgery to replace the natural lens. The IOL improves vision by restoring the focusing power of the eye.
Multifocal IOLs:
Multifocal IOLs (MIOLS) are intraocular lenses that can provide two or more distinct images at the same time with different focal points. It is a type of intraocular lens which consists of two or more optical zones, each with its own independent lens position and focusing mechanism.
Accommodating IOLs:
Accommodating IOLs are used to increase the visual acuity in patients with decreased vision. They are also useful for treating presbyopia and myopia. The increasing prevalence of these conditions is expected to boost demand for accommodating IOLs over the forecast period.
The global premium intraocular lens market was valued at USD 1,15,000 in 2015.
Application Insights:
The hospitals and clinics segment dominated the global premium intraocular lens market in 2017. This is attributed to a high adoption rate of premium IOLs in hospitals and clinics across the globe. Premium IOLs are more expensive than conventional ones; however, their prices are justified by their higher performance as compared to conventional lenses. Hospitals and clinics that offer surgical treatment for patients with eye diseases have become major users of these lenses due to a large patient pool who require surgery for better vision outcomes.
ASC accounted for a smaller share in comparison with hospital or clinic settings owing to various factors such as lack of expertise, infrastructural constraints, unavailability of advanced equipment etc. However, this segment is expected to grow at lucrative rates over the forecast period due primarily to increasing demand from developing countries such as China India etc.
Regional Analysis:
North America dominated the global premium intraocular lens market in 2017. The rising prevalence of cataract and increasing geriatric population are some of the major factors contributing to market growth in this region. According to Ocrilege, LLC, there were around 25 million Americans suffering from cataract as of 2016 and it is anticipated that by 2025 this number will reach around 33 million. In addition, an increase in per capita healthcare expenditure along with favorable reimbursement policies for premium lenses is expected to boost their adoption over the forecast period.
The Asia Pacific region is expected witness lucrative growth over the forecast period due its large aging population base coupled with growing awareness about eye care facilities among people especially those working abroad or migrated permanently from developed countries such as U.S.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for premium intraocular lenses.
- Rising prevalence of eye diseases: The prevalence of various eye diseases, such as cataract, glaucoma, and age-related macular degeneration (AMD), is rising which is expected to boost the demand for premium intraocular lenses.
- Technological advancements: There has been a significant advancement in the technology used for manufacturing premium intraocular lenses in recent years which is likely to fuel their demand over the forecast period.
- Growing awareness about benefits of premium intraocular lenses: There has been an increase in awareness about the benefits of using premium intraocular lenses among patients and healthcare professionals which is likely to propel their demand over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Premium Intraocular Lens Market Research Report
By Type
Multifocal IOLs, Accommodating IOLs, Extended Depth of Focus IOLs
By Application
Hospitals and Clinics, Ambulatory Surgery Centers (ASC)
By Companies
Alcon, Inc. (US) (Novartis AG (Switzerland)), Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada)), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (US), Rayner Intraocular Lenses Limited (UK), PhysIOL (Belgium), Ophtec BV (Netherlands), Swiss Advanced Vision (SAV IOL) (Switzerland), Alcon, Inc. (US) (Novartis AG (Switzerland)), NIDEK CO., LTD. (Japan), Aurolab (India)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Premium Intraocular Lens Market Report Segments:
The global Premium Intraocular Lens market is segmented on the basis of:
Types
Multifocal IOLs, Accommodating IOLs, Extended Depth of Focus IOLs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Ambulatory Surgery Centers (ASC)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alcon, Inc. (US) (Novartis AG (Switzerland))
- Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada))
- Johnson & Johnson Vision Care, Inc. (US)
- Carl Zeiss Meditec (Germany)
- HOYA Corporation (Japan)
- STAAR Surgical Company (US)
- Rayner Intraocular Lenses Limited (UK)
- PhysIOL (Belgium)
- Ophtec BV (Netherlands)
- Swiss Advanced Vision (SAV IOL) (Switzerland)
- Alcon, Inc. (US) (Novartis AG (Switzerland))
- NIDEK CO., LTD. (Japan)
- Aurolab (India)
Highlights of The Premium Intraocular Lens Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Multifocal IOLs
- Accommodating IOLs
- Extended Depth of Focus IOLs
- By Application:
- Hospitals and Clinics
- Ambulatory Surgery Centers (ASC)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Premium Intraocular Lens Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Premium intraocular lenses (PILs) are a type of artificial lens that are used to correct vision in people with nearsightedness, farsightedness, or astigmatism. PILs are inserted into the eye using a surgery.
Some of the major companies in the premium intraocular lens market are Alcon, Inc. (US) (Novartis AG (Switzerland)), Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada)), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (US), Rayner Intraocular Lenses Limited (UK), PhysIOL (Belgium), Ophtec BV (Netherlands), Swiss Advanced Vision (SAV IOL) (Switzerland), Alcon, Inc. (US) (Novartis AG (Switzerland)), NIDEK CO., LTD. (Japan), Aurolab (India).
The premium intraocular lens market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Premium Intraocular Lens Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Premium Intraocular Lens Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Premium Intraocular Lens Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Premium Intraocular Lens Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Premium Intraocular Lens Market Size & Forecast, 2020-2028
4.5.1 Premium Intraocular Lens Market Size and Y-o-Y Growth
4.5.2 Premium Intraocular Lens Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Multifocal IOLs
5.2.2 Accommodating IOLs
5.2.3 Extended Depth of Focus IOLs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Ambulatory Surgery Centers (ASC)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Premium Intraocular Lens Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Premium Intraocular Lens Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Multifocal IOLs
9.6.2 Accommodating IOLs
9.6.3 Extended Depth of Focus IOLs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Ambulatory Surgery Centers (ASC)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Multifocal IOLs
10.6.2 Accommodating IOLs
10.6.3 Extended Depth of Focus IOLs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Ambulatory Surgery Centers (ASC)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Multifocal IOLs
11.6.2 Accommodating IOLs
11.6.3 Extended Depth of Focus IOLs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Ambulatory Surgery Centers (ASC)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Multifocal IOLs
12.6.2 Accommodating IOLs
12.6.3 Extended Depth of Focus IOLs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Ambulatory Surgery Centers (ASC)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Multifocal IOLs
13.6.2 Accommodating IOLs
13.6.3 Extended Depth of Focus IOLs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Ambulatory Surgery Centers (ASC)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Premium Intraocular Lens Market: Competitive Dashboard
14.2 Global Premium Intraocular Lens Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alcon, Inc. (US) (Novartis AG (Switzerland))
14.3.2 Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada))
14.3.3 Johnson & Johnson Vision Care, Inc. (US)
14.3.4 Carl Zeiss Meditec (Germany)
14.3.5 HOYA Corporation (Japan)
14.3.6 STAAR Surgical Company (US)
14.3.7 Rayner Intraocular Lenses Limited (UK)
14.3.8 PhysIOL (Belgium)
14.3.9 Ophtec BV (Netherlands)
14.3.10 Swiss Advanced Vision (SAV IOL) (Switzerland)
14.3.11 Alcon, Inc. (US) (Novartis AG (Switzerland))
14.3.12 NIDEK CO., LTD. (Japan)
14.3.13 Aurolab (India)
